Tag Archives: Sanofi

Dare to Compare: Genzyme Bets on MS

Riding positive data on a late-phase multiple sclerosis drug, Genzyme execs talked up the company’s willingness to go head-to-head against Rebif, EMD Serono and Pfizer’s blockbuster beta interferon. Genzyme execs didn’t go so far as to reiterate former CEO Henri Termeer’s 2010 prediction of $3 billion plus in potential sales for Lemtrada (alemtuzumab), but they […]
Posted in Biotech, Events, FDA, Global, IP, R&D, Regulatory, Safety, Sales, Strategy, Technology | Also tagged , , | 1 Comment

ePharma Summit: Less Proselytizing, More Results

At the digital marketing-focused ePharma Summit in New York this week, many of the problems and frustrations related to the “big three” – Facebook, Twitter and YouTube – were hashed out for umpteenth time.
Posted in Advertising, E-Media, Events, Global, Marketing, patient education, Regulatory, social media, Strategy | Also tagged , , , | 1 Comment

European Pharma 1981-2011: Survival of the Fittest?

This month sees Pharmaceutical Executive magazine reach its 30th birthday. In line with that milestone, Reflector assesses what the last three decades have meant for European pharma — and shows how the game has changed beyond recognition. Thirty years is a long time in any industry. The coalmining industry, the market for air travel, or […]
Posted in Emerging Markets, Europe, Global, Guest Blog, healthcare, IP, leadership, Pharm Exec Magazine, R&D, Regulatory | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta